Insulin glargine and Limbrel250
Determining the interaction of Insulin glargine and Limbrel250 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
Generic Name: bioflavonoids / zinc glycinate
Brand name: Limbrel250, Limbrel500
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine-Limbrel500
- Insulin glargine-Limencin
- Insulin glargine-Linaclotide
- Insulin glargine-Linagliptin
- Insulin glargine-Linagliptin and metformin
- Insulin glargine-Linagliptin and Metformin Extended-Release Tablets
- Limbrel250-Insulin Glargine (U-100) Cartridge Systems and Pens
- Limbrel250-Insulin Glargine (U-100) Vials
- Limbrel250-Insulin Glargine (U-300) Pens
- Limbrel250-Insulin glargine and lixisenatide
- Limbrel250-Insulin glargine and lixisenatide Subcutaneous
- Limbrel250-Insulin glargine, recombinant Subcutaneous